Top Markets
Coin of the day
Regnum Corp. Regnum Corp.

Regnum Corp.

RGMP
Kedudukan dalam Saham #42305
Regnum Corp. is dedicated to advancing and marketing therapeutic agents... Regnum Corp. is dedicated to advancing and marketing therapeutic agents designed to combat both rare and infectious diseases. Its flagship product is Leronlimab (PRO 140), a monoclonal antibody functioning as a C-C chemokine receptor type 5 (CCR5) antagonist. This drug is specifically formulated to inhibit the human immunodeficiency virus (HIV) from gaining entry into human cells. Headquartered in New York, New York, Regnum Corp. operates as a subsidiary of Phoenixus AG.
Harga Saham
$0.0001
Disegerakkan terakhir: 2026-08-11
Modal Pasaran
$2.30K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Regnum Corp. (RGMP)

Kategori

Sejarah harga saham bagi Regnum Corp. (RGMP)
Harga penutupan tertinggi: $0.00 pada 2026-08-01

Harga penutupan terendah: $0.15 pada 2019-05-01
Sejarah harga saham Regnum Corp. dari 2019 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 0.00%
2025 0.00%
2024 -98.31%
2023 -96.26%
2022 94.68%
2021 -67.77%
2020 114.71%
2019 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR